Results 111 to 120 of about 7,028 (149)

Prognostic Value of Immunohistochemical T-Cell Marker Loss in Early-Stage Mycosis Fungoides: A Single-Center Cohort Study. [PDF]

Dermatopathology (Basel)
Jerkovic Gulin S, Ilic I, Gulin D, Kravvas G, Ceovic R.   +4 more
europepmc   +1 more source

Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification. [PDF]

Curr Hematol Malig Rep
Loghavi S, Hasserjian RP.
europepmc   +1 more source

Flow Cytometric Assessment of TRBC1 Expression for the Diagnosis of T-Cell Lymphoma: Clinical Utility and Pitfalls Related to T-Cell Clones of Uncertain Significance. [PDF]

Int J Lab Hematol
Yu S, Kim B, Yoon SE, Kim HJ, Kim HY.
europepmc   +1 more source

Antigen-directed p53 restoration in <i>TP53</i>-mutated myeloid neoplasms: a hypothesis and theory perspective. [PDF]

Front Oncol
Medawar G, Pyle S, Baratam P, Coltoff A.
europepmc   +1 more source

Composite lymphoma composed of follicular lymphoma and nodal T-follicular helper cell lymphoma: report of 3 cases highlighting histopathologic zonation of each neoplastic component. [PDF]

Am J Clin Pathol
Zhao Y, Hajjali I, Ju Y, Carrillo L, Feng M, Dong Q, Chen D, Siddiqi I, Wang E.   +8 more
europepmc   +1 more source

Tumour assessment of ROR1 levels in various adult leukaemia and lymphoma types. [PDF]

PLoS One
Silva MA, Williams S, Hauert S, Ovadia B, Gupta I, Waldmeier L, Jaimes Y, Al-Masri H.   +7 more
europepmc   +1 more source

Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panel. [PDF]

Haematologica
Wang SA, Arenillas L, Buccisano F, Bruggemann M, Kern W, Menes M, Plesa A, Stone L, Wellnitz D, Westerman DA, Wood BL, Freeman SD.   +11 more
europepmc   +1 more source

Flow cytometric detection of leukemic stem cells in Acute Myeloid Leukemia: current status and future directions. [PDF]

Front Pharmacol
Youssef MM, Park CY.
europepmc   +1 more source

Daratumumab and isatuximab differentially affect CD38 detection on plasma cells in myeloma: Anti-CD38 nanobody (clone JK36) and CD319 combination improve flow cytometric identification of plasma cells after targeted therapies. [PDF]

Br J Haematol
Shameli A, Catey T, Woodings V, Koepke O, Fromm JR, Cherian S.   +5 more
europepmc   +1 more source

Emerging genomic biomarkers in diagnosis and classification of T-cell acute lymphoblastic leukemia. [PDF]

Hematology Am Soc Hematol Educ Program
Xu J, Teachey DT.
europepmc   +1 more source